Actively Recruiting
How Do Adults With Cerebral Palsy Perceive Their Botulinum Toxin Treatment During Childhood ?
Led by Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française · Updated on 2026-05-14
500
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating how adults with cerebral palsy (CP) perceive the botulinum toxin injections they received during childhood. This observational study aims to understand the long-term impact of these repeated treatments, focusing on patient-centered perspectives including treatment effectiveness, pain experienced, communication quality with healthcare providers, and coping strategies developed over time. The study addresses a gap in long-term data to improve future pediatric care and enhance quality of life for adults with CP. Participants will complete questionnaires about their experiences with childhood botulinum toxin treatments and their current coping methods. No new medical treatments are given as part of this study. The primary focus is on collecting patient-reported outcome measures at enrollment to assess treatment experience and coping strategies using tools like the BRIEF-Cope Scale. During the study, adults with CP will provide information through questionnaires about their past treatments and how they manage ongoing challenges. Researchers will evaluate these responses to better understand the emotional and physical burden of repeated toxin injections and the coping mechanisms used. This participation involves no interventional procedures and aims to inform improvements in care. The study is expected to start in February 2026 and continue through August 2026.
CONDITIONS
Brief Title
Childhood Toxin Perception Survey
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants aged 18 years or older
- Diagnosed with cerebral palsy
- Received repeated toxin injections during childhood (more than 2 series of injections)
- Agreeing to complete the questionnaire
- Possessing sufficient cognitive abilities, including reading and oral comprehension, even if assistance is needed
- All levels of the GMFCS classification 1 to 5
You will not qualify if you...
- Individuals who do not meet the inclusion criteria, as confirmed by responses in Part 1 of the survey, are excluded from the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - 1 day
Participants complete questionnaires regarding their perception of childhood botulinum toxin injections and their current coping strategies.
1 enrollment visit (in-person or remote)
Duration - Up to study completion
Participants' responses and coping strategies are observed without any further intervention.
No additional visits required
Trial Site Locations
Total: 1 location
1
CMCR des Massues
Lyon, France, 69005
Actively Recruiting
Research Team
D
Dr Emmanuelle Chaleat-Valayer
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here